Skip to main content

La Jolla Pharmaceutical Co

LJPCDelisted Aug 22, 2022
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0000920465

La Jolla Pharmaceutical Co was delisted on Aug 22, 2022; its insiders filed their last Form 4 on Aug 24, 2022; 41 institutions reported holding it in 13F filings for Q2 2022, worth $53.9M in total; no superinvestor held it.

Q2 2021 vs. Q1 2021

How the institutions holding La Jolla Pharmaceutical Co changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of LJPC: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders7662−14
Shares20.8M18.4M−2.43M (−11.7%)
Value$88.2M$78.6M−$9.57M (−10.9%)

New holders (9)

Institutions that held La Jolla Pharmaceutical Co at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to LJPC in Q2 2021
InstitutionSharesValue% of portfolio
Ergoteles LLC82,400$353.0K0.01%
Tibra Equities Europe Ltd72,600$311.0K0.10%
Gsa Capital Partners LLP52,749$226.0K0.03%
HRT Financial LP50,376$215.0K0.00%
Summit Global Investments48,500$208.0K0.01%
Citadel Advisors LLC18,967$81.0K0.00%
Marshall Wace, LLP15,572$67.0K0.00%
LMR Partners LLP11,515$49.0K0.00%
FMR LLC500$2.00K0.00%

Sold out (23)

Institutions that held La Jolla Pharmaceutical Co at the end of Q1 2021 and filed for Q2 2021 without it.